Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Percutaneous edge-to-edge repair for common atrioventricular valve regurgitation in a patient with heterotaxy syndrome, single ventricle physiology, and unbalanced atrioventricular septal defect.

Tan W, Calfon Press M, Lluri G, Aboulhosn J.

Catheter Cardiovasc Interv. 2020 Feb 19. doi: 10.1002/ccd.28782. [Epub ahead of print]

PMID:
32073720
2.

Perioperative Echocardiography in the Adult With Congenital Heart Disease.

Williams T, Lluri G, Boyd EK, Kratzert WB.

J Cardiothorac Vasc Anesth. 2019 Dec 7. pii: S1053-0770(19)31207-8. doi: 10.1053/j.jvca.2019.11.036. [Epub ahead of print] Review.

PMID:
32001150
3.

Angiopoietin-2 predicts morbidity in adults with Fontan physiology.

Shirali AS, Lluri G, Guihard PJ, Conrad MB, Kim H, Pawlikowska L, Boström KI, Iruela-Arispe ML, Aboulhosn JA.

Sci Rep. 2019 Dec 4;9(1):18328. doi: 10.1038/s41598-019-54776-w.

4.

Candida Parapsilosis Endocarditis Following Transcatheter Pulmonary Valve Implantation.

Tan W, Dora A, Lluri G, Aboulhosn J.

World J Pediatr Congenit Heart Surg. 2020 Jan;11(1):112-113. doi: 10.1177/2150135119883624. Epub 2019 Oct 28.

PMID:
31658874
5.

High-Output Heart Failure From Growth of Vascular Malformations in Multiple Gestation Pregnancy.

Srivastava PK, Vyas N, Jones J, Wong TC, Holliman K, Small AJ, Rao RR, Dowling EP, Finn JP, Duckwiler GR, Reardon LC, Aboulhosn JA, Ascher SB, Hogeling M, Lluri G, Yang EH.

Circ Heart Fail. 2019 Nov;12(11):e006561. doi: 10.1161/CIRCHEARTFAILURE.119.006561. Epub 2019 Oct 29. No abstract available.

6.

Risk factors for infective endocarditis following transcatheter pulmonary valve replacement in patients with congenital heart disease.

Sadeghi S, Wadia S, Lluri G, Tarabay J, Fernando A, Salem M, Sinha S, Levi DS, Aboulhosn J.

Catheter Cardiovasc Interv. 2019 Oct 1;94(4):625-635. doi: 10.1002/ccd.28474. Epub 2019 Aug 30.

PMID:
31471941
7.

Postoperative and short-term atrial tachyarrhythmia burdens after transcatheter vs surgical pulmonary valve replacement among congenital heart disease patients.

Wadia SK, Lluri G, Aboulhosn JA, Laks H, Biniwale RM, Van Arsdell GS, Levi DS, Salem MM, Shannon KM, Moore JP.

Congenit Heart Dis. 2019 Sep;14(5):838-845. doi: 10.1111/chd.12818. Epub 2019 Jul 7.

PMID:
31282099
8.

Early Experience With Sacubitril/Valsartan in Adult Patients With Congenital Heart Disease.

Lluri G, Lin J, Reardon L, Miner P, Whalen K, Aboulhosn J.

World J Pediatr Congenit Heart Surg. 2019 May;10(3):292-295. doi: 10.1177/2150135119825599.

PMID:
31084317
9.

The effects of pulmonary valve replacement on QRS duration in repaired tetralogy of Fallot patients with pulmonary regurgitation.

Aleligne Y, Eyvazian VA, Reardon L, Aboulhosn J, Moore JP, Lluri G.

J Electrocardiol. 2019 May - Jun;54:36-39. doi: 10.1016/j.jelectrocard.2019.02.010. Epub 2019 Feb 27.

PMID:
30856514
10.

Midline carcinoma expressing NUT in malignant effusion cytology.

Shenoy KD, Stanzione N, Caron JE, Fishbein GA, Abtin F, Lluri G, Hirschowitz SL.

Diagn Cytopathol. 2019 Jun;47(6):594-598. doi: 10.1002/dc.24150. Epub 2019 Feb 8.

PMID:
30734527
11.

Thromboprophylaxis in Adults With Atrio-Pulmonary Fontan.

Small AJ, Aboulhosn JA, Lluri G.

World J Pediatr Congenit Heart Surg. 2018 Sep;9(5):504-508. doi: 10.1177/2150135118772837.

PMID:
30157726
12.

Implantation techniques and outcomes after cardiac resynchronization therapy for congenitally corrected transposition of the great arteries.

Moore JP, Cho D, Lin JP, Lluri G, Reardon LC, Aboulhosn JA, Hageman A, Shannon KM.

Heart Rhythm. 2018 Dec;15(12):1808-1815. doi: 10.1016/j.hrthm.2018.08.017. Epub 2018 Aug 18.

PMID:
30125719
13.

One-Year Outcomes of Orbital Atherectomy of Long, Diffusely Calcified Coronary Artery Lesions.

Lee MS, Shlofmitz E, Lluri G, Park KW, Hollowed J, Shlofmitz R.

J Invasive Cardiol. 2018 Jun;30(6):230-233.

14.

Ventricular arrhythmia burden after transcatheter versus surgical pulmonary valve replacement.

Wadia SK, Lluri G, Aboulhosn JA, Shivkumar K, Reemtsen BL, Laks H, Biniwale RM, Levi DS, Salem M, Moore JP.

Heart. 2018 Nov;104(21):1791-1796. doi: 10.1136/heartjnl-2017-312769. Epub 2018 Apr 10.

PMID:
29636402
15.

Role of Percutaneous Coronary Intervention in the Treatment of Cardiac Allograft Vasculopathy.

Lee MS, Lluri G, Finch W, Park KW.

Am J Cardiol. 2018 May 1;121(9):1051-1055. doi: 10.1016/j.amjcard.2018.01.025. Epub 2018 Feb 6.

PMID:
29598855
16.

Impact of the Use of Intravascular Imaging on Patients Who Underwent Orbital Atherectomy.

Lee MS, Shlofmitz E, Kong J, Lluri G, Srivastava PK, Shlofmitz R.

J Invasive Cardiol. 2018 Feb;30(2):77-80.

17.

WNT Signaling in Cardiac and Vascular Disease.

Foulquier S, Daskalopoulos EP, Lluri G, Hermans KCM, Deb A, Blankesteijn WM.

Pharmacol Rev. 2018 Jan;70(1):68-141. doi: 10.1124/pr.117.013896. Review.

18.

Incidence and outcome of infective endocarditis following percutaneous versus surgical pulmonary valve replacement.

Lluri G, Levi DS, Miller E, Hageman A, Sinha S, Sadeghi S, Reemtsen B, Laks H, Biniwale R, Salem M, Fishbein GA, Aboulhosn J.

Catheter Cardiovasc Interv. 2018 Feb 1;91(2):277-284. doi: 10.1002/ccd.27312. Epub 2017 Sep 12.

PMID:
28895275
19.

Prognostic Significance of Left Ventricular Fibrosis in Patients With Congenital Bicuspid Aortic Valve.

Lluri G, Renella P, Finn JP, Vorobiof G, Aboulhosn J, Deb A.

Am J Cardiol. 2017 Oct 1;120(7):1176-1179. doi: 10.1016/j.amjcard.2017.06.060. Epub 2017 Jul 14.

20.

Outcomes of patients with myocardial infarction who underwent orbital atherectomy for severely calcified lesions.

Lee MS, Shlofmitz E, Lluri G, Kong J, Neverova N, Shlofmitz R.

Cardiovasc Revasc Med. 2017 Oct - Nov;18(7):497-500. doi: 10.1016/j.carrev.2017.05.005. Epub 2017 May 7.

PMID:
28529094
21.

Outcomes in Elderly Patients With Severely Calcified Coronary Lesions Undergoing Orbital Atherectomy.

Lee MS, Shlofmitz E, Lluri G, Shlofmitz RA.

J Interv Cardiol. 2017 Apr;30(2):134-138. doi: 10.1111/joic.12362. Epub 2017 Jan 23.

PMID:
28116818
22.

Impact of Impaired Renal Function in Patients With Severely Calcified Coronary Lesions Treated With Orbital Atherectomy.

Lee MS, Shlofmitz E, Lluri G, Shlofmitz RA.

J Invasive Cardiol. 2017 Jun;29(6):203-206. Epub 2017 Jan 15.

23.

Hematopoietic progenitors are required for proper development of coronary vasculature.

Lluri G, Huang V, Touma M, Liu X, Harmon AW, Nakano A.

J Mol Cell Cardiol. 2015 Sep;86:199-207. doi: 10.1016/j.yjmcc.2015.07.021. Epub 2015 Aug 1.

24.

Systemic to pulmonary venous collaterals in adults with single ventricle physiology after cavopulmonary palliation.

Lluri G, Levi DS, Aboulhosn J.

Int J Cardiol. 2015 Jun 15;189:159-63. doi: 10.1016/j.ijcard.2015.04.065. Epub 2015 Apr 10.

PMID:
25897896
25.

Applications of cardiac CT in the tetralogy of Fallot patient.

Lluri G, Aboulhosn JA, Moriarty JM, Finn JP, Ruehm SG, Budoff MJ, Vorobiof G, Yang EH.

JACC Cardiovasc Imaging. 2014 Dec;7(12):1276-9. doi: 10.1016/j.jcmg.2014.04.025. No abstract available.

26.

Giant left atrial appendage mimicking a mediastinal mass in a new diagnosis of atrial septal defect and pulmonic stenosis.

Yang EH, Moriarty JM, Lluri G, Aboulhosn JA.

Int J Cardiol. 2014 Aug 1;175(2):e27-9. doi: 10.1016/j.ijcard.2014.04.122. Epub 2014 Apr 18. No abstract available.

27.

Coronary arterial development: a review of normal and congenitally anomalous patterns.

Lluri G, Aboulhosn J.

Clin Cardiol. 2014 Feb;37(2):126-30. doi: 10.1002/clc.22237. Epub 2014 Jan 7. Review.

28.

Comparison of sirolimus-, paclitaxel-, and everolimus-eluting stent in unprotected left main coronary artery percutaneous coronary intervention.

Lee MS, Mahmud E, Ang L, Lluri G, Cheng RK, Aragon J, Sheiban I.

J Saudi Heart Assoc. 2013 Apr;25(2):75-8. doi: 10.1016/j.jsha.2013.03.001. Epub 2013 Mar 14.

29.

Left and right ventricular diastolic function in adults with surgically repaired tetralogy of Fallot: a multi-institutional study.

Aboulhosn JA, Lluri G, Gurvitz MZ, Khairy P, Mongeon FP, Kay J, Valente AM, Earing MG, Opotowsky AR, Lui G, Gersony DR, Cook S, Child J, Ting J, Webb G, Landzberg M, Broberg CS; Alliance for Adult Research in Congenital Cardiology (AARCC).

Can J Cardiol. 2013 Jul;29(7):866-72. doi: 10.1016/j.cjca.2012.11.003. Epub 2013 Jan 28.

PMID:
23369488
30.

Radiation coronary arteritis refractory to surgical and percutaneous revascularization culminating in orthotopic heart transplantation.

Cheng RK, Lee MS, Seki A, Shemin RJ, Cruz D, Lluri G, Mitchell GD, Yang EH.

Cardiovasc Pathol. 2013 Jul-Aug;22(4):303-8. doi: 10.1016/j.carpath.2012.12.005. Epub 2013 Jan 26.

PMID:
23357623
31.

Fibromuscular dysplasia of the left anterior descending coronary artery.

Lluri G, Provias T, Yang EH, Lee MS.

JACC Cardiovasc Interv. 2012 Apr;5(4):e11-2. doi: 10.1016/j.jcin.2011.10.018. No abstract available.

32.

Tissue inhibitor of metalloproteinase-2 (TIMP-2) regulates myogenesis and beta1 integrin expression in vitro.

Lluri G, Langlois GD, Soloway PD, Jaworski DM.

Exp Cell Res. 2008 Jan 1;314(1):11-24. Epub 2007 Jun 27.

33.

Potential regulatory relationship between the nested gene DDC8 and its host gene tissue inhibitor of metalloproteinase-2.

Jaworski DM, Beem-Miller M, Lluri G, Barrantes-Reynolds R.

Physiol Genomics. 2007 Jan 17;28(2):168-78. Epub 2006 Sep 19.

34.

Tissue inhibitor of metalloproteinase-2 (TIMP-2) regulates neuromuscular junction development via a beta1 integrin-mediated mechanism.

Lluri G, Langlois GD, McClellan B, Soloway PD, Jaworski DM.

J Neurobiol. 2006 Oct;66(12):1365-77.

35.

Supplemental Content

Support Center